Press release
Tardive Dyskinesia (TD) Treatment Drugs Market Is Expanding At CAGR Of 3.7% From 2018 To 2026 - Credence Research
Browse the full report Tardive Dyskinesia (TD) Treatment Drugs Market - Growth, Future Prospects and Competitive Analysis, 2018 – 2026 report at http://www.credenceresearch.com/report/tardive-dyskinesia-td-treatment-drugs-market
Market Insights
Tardive dyskinesia (TD) treatment drugs market is expected to show significant market growth over the forecast period due to increase in incidence of TD, rising number of antipsychotic prescriptions, developing healthcare infrastructure and presence of late stage pipeline molecule. The global TD treatment drugs market is categorized on the basis of drug type such as valbenazine, deutetrabenazine and others (benzodiazepines, botulinum toxin, vitamin E, amantadine, levodopa, reserpine, dopamine-depleting agents and calcium channel blockers etc.). It is observed that the demand for valbenazine and deutetrabenazine is highest in market due to the efficacy and target specificity. Valbenazine and deutetrabenazine were approved in 2017. Furthermore, being the only approved drugs in the market, these drugs will experience significant demand.
Neurocrine Biosciences announced that the recently approved, Ingrezza (valbenazine) achieved $45.8 million net sales in third quarter in 2017. Expected launch of pipeline drug such as SNC-102 (Synchroneuron) would further drive the market growth during forecast period. Currently, North America leads the global TD treatment drugs market due to higher cost of therapeutics, early diagnosis of the disease and increase in prevalence of TD. It is predicted that TD treatment drugs market in Asia Pacific will grow significantly in coming years due to growing number of affected population and emerging healthcare infrastructure.
Market Competition Assessment:
Currently, only two drugs Valbenazine by Neurocrine Biosciences, Inc. and Deutetrabenazine by Teva Pharmaceutical Industries Ltd. are approved by US-FDA for the treatment of TD. Key players involved in R&D activities are Synchroneuron Inc. (SNC-102) and Auspex Pharmaceuticals (SD–809).
Browse the full report at http://www.credenceresearch.com/report/tardive-dyskinesia-td-treatment-drugs-market
Browse More Reports From This Category @ http://www.credenceresearch.com/industry/pharmaceuticals-market
Blog @ http://www.mobilecomputingtoday.co.uk/7376/tardive-dyskinesia-treatment-drugs-market-expanding-cagr-3-7-2018-2026-credence-research/
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Name: Chris Smith
Designation: Global Sales Manager
Address : 105 N 1st ST #429, SAN JOSE, CA 95103, United States
E-mail: sales@credenceresearch.com
Ph: 1-800-361-8290
Web: http://www.credenceresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Tardive Dyskinesia (TD) Treatment Drugs Market Is Expanding At CAGR Of 3.7% From 2018 To 2026 - Credence Research here
News-ID: 906095 • Views: …
More Releases from Credence Research Inc
ePrison Market is gaining huge growth |Market valued at US$ 1.81 Bn in 2018
The global ePrison market was valued at US$ 1.81 Bn in 2018 and is expected to expand at a CAGR of 6.2% during the forecast from 2019 to 2027.
Market Insight
ePrison solutions help administrators of correctional homes & prisons to get real-time access to information about staff and prison inmates, thereby helping to ensure discipline, safety, and gauge the needs of inmates. The use of these solutions is not only limited…
Cochlear Implants Market - Growth, Future Prospects & Competitive Analysis, 2018 …
Cochlear Implants– Global Market Size, Analysis, Share, Trends, Growth and Forecast to 2026 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).
The report firstly introduced the Cochlear Implants: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures and…
Marine Internet Of Things (IoT) Market Growth, Future Prospects & Competitive An …
Marine Internet Of Things (IoT)– Global Market Size, Analysis, Share, Trends, Growth and Forecast to 2026 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).
The report firstly introduced the Marine Internet Of Things (IoT): definitions, classifications, applications and market overview; product…
Laundry Care Market : Key Trends with Market size, Industry Share, Market player …
Credence Research lately added a new report titled "Laundry Care Market - Industry Size, Global Trends, Growth, Opportunities, Market Share and Market Forecast - 2018 to 2026" to its repository. This latest research study investigates the Laundry Care market through different segments primarily based on type, application and end-use, market participants, areas and presents country-level evaluation over the forecast period from 2018 to 2026.
Browse Here For Full Report with ToC:…
More Releases for Tardive
Tardive Dyskinesia Treatment Market Analysis By Drug Class & Distribution Channe …
The Tardive Dyskinesia Treatment Market is expected to Reach a CAGR of 4% during the forecast period (2024-2031).
Tardive Dyskinesia Treatment Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it…
Tardive Dyskinesia Market Report and Forecast 2024-2032
The tardive dyskinesia market size is anticipated to grow at a CAGR of 3.2 % during the forecast period of 2024-2032, driven by growing awareness about the importance of monitoring patients on long-term antipsychotic therapy for early signs of tardive dyskinesia in the major markets.
Tardive Dyskinesia: Introduction
Tardive dyskinesia is a neurological disorder characterized by involuntary, repetitive body movements. It primarily affects the face, causing grimacing, blinking, or lip-smacking, but can…
Global Tardive Dyskinesia (TD) Treatment Market - Opportunities & Forecasts, 202 …
Dhirtek Business Research and Consulting recently released its most comprehensive research report to date on the global tardive dyskinesia (td) treatment market. Through extensive research, analysts have provided an extensive look into the market's drivers and restraints, and identified the key milestones and trends that will shape its future.
Primary and secondary research methods were used to create this in-depth report. Through the analysis of the research, Dhirtek was able to…
Tardive Dyskinesia Drugs Market Competitor Landscape, Opportunity Analysis, Grow …
Tardive neurological disorder (TD) may be a kind of dyskinesia that's tough to treat. it's a nerve disorder characterised by involuntary movements like jaw, lips, and tongue, thought-about as grimacing, protrusive the tongue out, and lip smack. another symptoms square measure a private experiencing involuntary movement of the lower and higher extremities and additionally respiratory choking.
Get HOLISTIC Request Sample Copy:https://www.coherentmarketinsights.com/insight/request-sample/218
consistent with Center for Drug analysis and analysis, dyskinesia will…
Tardive Dyskinesia (TD) Treatment Drugs Market Size, Share, Development by 2024
LP INFORMATION offers a latest published report on Tardive Dyskinesia (TD) Treatment Drugs Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Tardive Dyskinesia (TD) Treatment Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$…
Antioxidants May Aid in the Treatment of Tardive Dyskinesia
Memphis, TN (May 9, 2019) – Today, The Primary Care Companion for CNS Disorders published a case report on the use of antioxidants in the treatment of tardive dyskinesia. While new pharmacologic discoveries have occurred in the area of movement disorders, their use comes with a large price tag. Thus, for mild cases, clinicians may want to seek out more cost-effective options. Antioxidants may serve a role in the prevention…
